Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entolimod on Immunosenescence in Elderly Flu Vaccination
NCT04176133Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of entolimod in influenza. Started Oct 2019; status: completed.
02
Drugs
entolimod
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04176133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176133.